Fig. 1

The mRNA based expression profiling of LZTS2 across 24 types of cancerous tissues paired with corresponding controls using pan-cancer analysis via TIMER and GENT2. (A) TIMER, (B) GENT2 (Data were normalized to TPM, log2-transformed, and adjusted for batch effects using ComBat).